Todd Golub

Todd Golub is an American physician-scientist and a central figure in the fields of cancer genomics and computational biology. He is renowned for pioneering the use of DNA microarray technology to classify human cancers based on their molecular signatures, fundamentally shifting oncology from histology-based to genomics-driven diagnosis. Golub serves as the Director of the Broad Institute of MIT and Harvard, the Charles A. Dana Investigator in Human Cancer Genetics at the Dana–Farber Cancer Institute, and a Professor of Pediatrics at Harvard Medical School. His work has been instrumental in large-scale projects like The Cancer Genome Atlas and in founding several biotechnology companies.

Early life and education

Golub was born in the United States and developed an early interest in the biological sciences. He completed his undergraduate studies at the University of California, San Diego, where he earned a degree in biology. He then pursued his medical doctorate at the Pritzker School of Medicine of the University of Chicago, graduating with honors. Following his medical training, he sought to integrate clinical medicine with basic research, completing a residency in pediatrics and a fellowship in pediatric hematology-oncology at the Boston Children's Hospital and the Dana–Farber Cancer Institute.

Career and research

Golub's research career has been defined by applying genomic technologies to understand and combat cancer. As a fellow at the Whitehead Institute at the Massachusetts Institute of Technology (MIT), he collaborated with Eric Lander and others to develop some of the first methods for using gene expression patterns to distinguish between different cancer types, a foundational concept for molecular diagnostics. He subsequently joined the faculty of Harvard Medical School and the Dana–Farber Cancer Institute, where he established his own laboratory. A pivotal moment was his co-founding of the Broad Institute in 2004, where he later became the Director and helped establish it as a global epicenter for genomic medicine. His laboratory has made significant contributions to The Cancer Genome Atlas project, identified novel leukemia subtypes, and discovered new therapeutic targets. His work has also led to the creation of several companies, including Foundation Medicine, which commercializes comprehensive genomic profiling for cancer patients.

Awards and honors

Golub's contributions have been recognized with numerous prestigious awards in biomedical research. These include the Meyenburg Prize from the German Cancer Research Center, the Paul Marks Prize for Cancer Research from the Memorial Sloan Kettering Cancer Center, and the American Association for Cancer Research-Kirk A. Landon Award. He is an elected member of the National Academy of Medicine and the American Academy of Arts and Sciences, honors that underscore his impact on both science and public health. He has also been a Howard Hughes Medical Institute Investigator, a highly competitive fellowship supporting the nation's most innovative scientists.

Personal life

Golub maintains a private personal life, with details largely kept out of the public sphere. He is known to be an avid supporter of science education and mentorship, actively guiding the next generation of researchers at the Broad Institute and Harvard University. His commitment extends to fostering interdisciplinary collaboration between biologists, chemists, and computational scientists to tackle complex problems in human disease.

Selected publications

Golub has authored hundreds of highly influential scientific papers. Key publications include the seminal 1999 paper in *Science* on molecular classification of cancer, a foundational 2002 paper in *Nature* on multigene predictors of outcome in acute myeloid leukemia, and major contributions to pan-cancer analyses from The Cancer Genome Atlas published in *Cell* and *Nature*. His work is frequently published in top-tier journals and has been cited tens of thousands of times, reflecting its profound influence on the field of oncology and biomedical research.

Category:American cancer researchers Category:Harvard Medical School faculty Category:Members of the National Academy of Medicine